- At their annual shareholder's meeting, Third Wave Technologies
announced increased revenues for the first quarter 2006 and several promising ventures for the rest of the year, but company officials still were unable to say when they would begin to show profit.
Kevin Conroy, president and chief executive officer of Third Wave, told as......Full article >>>
all Street last year, and it takes a while to regain market confidence," he said.
In addition to altered expectations, the company also has had to deal with legal issues over its Invader technology, a product line that includes tests for genetic mutations associated with immune response and drug metabolism. In October of 2005, Third Wave filed patent lawsuits against multiple companies, a......Full article >>>
market at $80 million.
Lai said getting repeat customers and partnerships like these will be a key to Third Wave's progress. "The molecular diagnostics field is very competitive, and once you get a base of users through the field, they tend to be very sticky, they adopt your technology, and become a great space," Lai said. "Third Wave is showing signs of traction in selling their diagnos......Full article >>>
Source:wistechnology.com By Les Chappell 06/13/06Related biology technology :1
. Third Wave files countersuit vs. Digene in patent case2
. Third Wave reports net loss of $18.9M for 20063
. Stratagene to pay Third Wave $10.75M in patent case4
. Third Wave responds to Digene patent lawsuit5
. Third Wave seeks approval of Cystic Fibrosis test6
. Third Wave Technologies to raise $14.9M through private debt7
. Third Wave reports $5.2M third quarter loss8
. Third Wave reports another loss, stronger sales9
. Napier joins board of Third Wave Technologies10
. Third Wave reports clinical growth, continued loss11
. Third Wave announces two senior management appointments